⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL906547 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL6820706 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL16540232 | 0.67 | — | — | |
| SCHEMBL4760503 | 0.64 | — | — | |
| SCHEMBL12494680 | 0.59 | — | — | |
| SCHEMBL28060956 | 0.58 | — | — | |
| SCHEMBL21180932 | 0.57 | — | — | |
| Water SCHEMBL8209107 | 0.57 | — | — | |
| SCHEMBL10479106 | 0.57 | — | — | |
| Water SCHEMBL27800312 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2751069-B1 | METHOD FOR PRODUCING EDDN AND/OR EDMN | BASF SE (DE) | 2017-10-11 | — | — | EP | disclosed |
| EP-2751065-B1 | METHOD FOR PRODUCING EDDN AND/OR EDMN THROUGH THE CONVERSION OF EDFA AND/OR EDMFA WITH HCN | BASF SE (DE) | 2016-11-16 | — | — | EP | disclosed |
| US-9096497-B2 | Process for preparing EDDN and EDMN | BASF SE (DE) | 2015-08-04 | — | — | US | disclosed |
| US-9012638-B2 | Process for preparing EDDN and/or EDMN by conversion of FACH and EDA | BASF SE (DE) | 2015-04-21 | — | — | US | disclosed |
| US-8952156-B2 | Process for working up reaction outputs from the hydrogenation of EDDN or EDMN | BASF SE (DE) | 2015-02-10 | — | — | US | disclosed |
| US-8946459-B2 | Process for preparing EDDN and/or EDMN by reacting EDFA and/or EDMFA with HCN | BASF SE (DE) | 2015-02-03 | — | — | US | disclosed |
| EP-2751067-A1 | METHOD FOR PROCESSING REACTION PRODUCT STEMMING FROM THE HYDROGENATION OF EDDN OR EDMN | BASF SE (DE) | 2014-07-09 | — | — | EP | disclosed |
| EP-2751066-A1 | METHOD FOR PRODUCING EDFA AND/OR EDMFA AND DETA AND/OR TETA | BASF SE (DE) | 2014-07-09 | — | — | EP | disclosed |
| EP-2751069-A1 | METHOD FOR PRODUCING EDDN AND/OR EDMN | BASF SE (DE) | 2014-07-09 | — | — | EP | disclosed |
| EP-2751068-A1 | METHOD FOR PRODUCING EDDN AND/OR EDMN BY CONVERTING FACH AND EDA | BASF SE (DE) | 2014-07-09 | — | — | EP | disclosed |
| WO-2013030254-A1 | METHOD FOR THE PRODUCTION OF TETA AND/OR DETA | BASF SE (DE) | 2013-03-07 | — | — | WO | disclosed |
| WO-2013030258-A1 | METHOD FOR PROCESSING REACTION PRODUCT STEMMING FROM THE HYDROGENATION OF EDDN OR EDMN | BASF SE (DE) | 2013-03-07 | — | — | WO | disclosed |
| US-20130053536-A1 | PROCESS FOR PREPARING EDDN AND/OR EDMN AND A PROCESS FOR PREPARING DETA AND/OR TETA | BASF SE (DE) | 2013-02-28 | — | — | US | disclosed |
| US-20130053538-A1 | PROCESS FOR PREPARING EDFA AND/OR EDMFA AND DETA AND/OR TETA | BASF SE (DE) | 2013-02-28 | — | — | US | disclosed |
| US-20130053584-A1 | PROCESS FOR PREPARING EDDN AND/OR EDMN BY REACTING EDFA AND/OR EDMFA WITH HCN | BASF SE (DE) | 2013-02-28 | — | — | US | disclosed |
| US-20130053539-A1 | PROCESS FOR PREPARING EDDN AND/OR EDMN AND PROCESS FOR PREPARING DETA AND/OR TETA | BASF SE (DE) | 2013-02-28 | — | — | US | disclosed |
| EP-0527181-A4 | HETEROCYCLICETHENEDIYL COMPOUNDS WHICH INHIBIT EGF RECEPTOR TYROSINE KINASE | — | 1993-04-07 | — | — | EP | disclosed |
| US-5196446-A | Treatment of psoriasis, atherosclerosis | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1993-03-23 | — | — | US | disclosed |
| EP-0527181-A1 | HETEROCYCLICETHENEDIYL COMPOUNDS WHICH INHIBIT EGF RECEPTOR TYROSINE KINASE | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1993-02-17 | — | — | EP | disclosed |
| WO-1991016305-A1 | HETEROCYCLICETHENEDIYL COMPOUNDS WHICH INHIBIT EGF RECEPTOR TYROSINE KINASE | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1991-10-31 | — | — | WO | disclosed |